[앵커]
As of today (9th) 0 o’clock, the number of new corona19 confirmed in Korea is expected to be less than 300. By 9 o’clock last night, 261 people were newly confirmed. Compared to the same time zone the day before, there are 14 fewer. I am desperate to hope that the number of infected people will decrease more clearly, but the spread has not completely stopped. In this situation, AstraZeneca vaccine will be available for the first time in Korea on the 24th.
This is Yoon Young-tak.
[기자]
AstraZeneca is the only vaccine that has a fixed delivery date.
I decided to receive the quantity produced by a domestic company.
[정은경/질병관리청장 : 150만 도스(75만명분)에 대해서는 2월 마지막 주에 공급 일정이 확정이 돼서 유통이나 배송에 대한 준비를 진행하고 있는 상황입니다.]
This is the first time that Commissioner Eun-kyung Jung has nailed the timing of introducing a vaccine.
The original plan was to fit the elderly and workers in nursing homes.
However, there was a controversy about the efficacy for the elderly over 65 years old.
Because of the lack of clinical trial data, it’s not clear if it will have an immune effect on older people.
In the UK and India, people over 65 years of age have been given vaccination.
However, Germany and France were limited to 65, Poland to 60, and Belgium to under 55.
Switzerland has withheld approval altogether.
Based on clinical trial data, different standards were applied for each country.
In particular, South Africa has stopped vaccination.
This is because it has been proven to be less effective against mutant viruses.
He said that our Food and Drug Administration should also make a careful decision.
Additional data are also being received and analyzed.
When approval from the Ministry of Food and Drug Safety is issued, the final decision is made by the Vaccination Committee.
A key official of the Expert Committee said in a phone call with JTBC reporters, “There is no reason to remove the highly safe vaccine from vaccination for the elderly, because there is no evidence that it is effective.
There is a high likelihood of vaccinating elderly people over the age of 65.
[최원석/고려대안산병원 감염내과 교수 : 시간이 지나면 아마 통계적 유의성을 확인할 수 있는 자료는 확보가 가능할 거라고 보고 있습니다.]
The Ministry of Food and Drug Safety is planning to announce the approval on the 10th.
The quarantine authorities have not yet come up with a definite answer for the Pfizer vaccine, which was scheduled to be available as the’first vaccine’ in mid-month.
He explained that the schedule could be adjusted, saying that administrative procedures with Kobax’s side remain.
(Video Design: Seonghyun Park)